AstraZeneca PLC (AZN) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for AstraZeneca PLC, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 26.53x | 28.64x | 34.84x | 64.13x | 1466.74x | 41.46x |
| P/B Ratio | 5.59x | 4.94x | 5.30x | 5.69x | 4.18x | 8.48x |
| P/S Ratio | 4.63x | 3.73x | 4.53x | 4.75x | 4.39x | 4.98x |
| Profitability | ||||||
| Gross Margin | 81.9% | 81.1% | 82.0% | 72.1% | 66.8% | 80.1% |
| Operating Margin | 23.4% | 18.5% | 17.9% | 8.5% | 2.8% | 19.4% |
| Net Margin | 17.5% | 13.0% | 13.0% | 7.4% | 0.3% | 12.0% |
| EBITDA Margin | 33.8% | 28.6% | 29.3% | 20.5% | 13.7% | 30.4% |
| Liquidity | ||||||
| Current Ratio | 0.94x | 0.93x | 0.82x | 0.86x | 1.16x | 0.96x |
| Quick Ratio | 0.72x | 0.74x | 0.64x | 0.68x | 0.76x | 0.76x |
| Leverage | ||||||
| Debt/Equity | 0.61x | 0.74x | 0.73x | 0.79x | 0.78x | 1.30x |
YoY = year-over-year change. Source: FMP..